drugset
drugset / Trial / NCT06252441

Comparative Clinical Study to Evaluate the Possible Efficacy and Safety of Oral N-Acetyl Cysteine Versus Rectal Diclofenac in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis

NCT06252441 ↗

Phase 1/2 Completed 46 enrolled Tanta University
RandomizedParallel-groupDouble-blindPrevention

Summary

The aim of the current study is to compare the efficacy and safety of oral NAC and rectal diclofenac in preventing Post Endoscopic retrograde cholangiopancreatography Pancreatitis. .

Timeline

Start
2024-03-16
Primary completion
2025-05-14
Completion
2025-06-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 100 mg Rectal
Comparator N-acetylcysteine Small molecule 1200 mg Oral

Indications

pancreatitis